Wagner M. Zago, Chief Scientific Officer at PROTHENA CORP PUBLIC LTD CO (PRTA), sold 37,706 shares at $71.96 ($2.7M) on 2023-06-07, disclosed to the SEC on 2023-06-07.
Scheduled sale ($2.7M) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.02 | 2,943 | $206K | 7.7% |
| 2 | $70.02 | 2,943 | $206K | 7.7% |
| 3 | $70.99 | 12,004 | $852K | 31.8% |
| 4 | $70.99 | 12,004 | $852K | 31.8% |
| 5 | $71.96 | 3,759 | $270K | 10.1% |
| 6 | $71.96 | 3,759 |
| $270K |
| 10.1% |
| 7 | $73.14 | 294 | $22K | 0.8% |
| Total | $71.05 avg | 37,706 | $2.7M | 100% |
| Filing → |
| PRTA | SELL | 2021-06-24 | $10.6M | — | Filing → |
| PRTA | SELL | 2021-02-19 | $192K | — | Filing → |
| PRTA | SELL | 2021-02-17 | $633K | — | Filing → |